Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Garber

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Docetaxel administered on a weekly basis for metastatic breast cancerH J Burstein, J Manola, J Younger, et al.
The New England Journal of Medicine|November 7, 1996
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1S C Rubin, I Benjamin, K Behbakht, et al.
Cancer Research|January 13, 2001
Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancerP Seth, K L Lunetta, D W Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programsM Dorval, A F Patenaude, K A Schneider, et al.
American Journal of Human Genetics|April 17, 1999
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeatT R Rebbeck, P W Kantoff, K Krithivas, et al.
Journal of Medical Genetics|July 31, 2007
Germline E-cadherin mutations in familial lobular breast cancerS Masciari, N Larsson, J Senz, et al.
Cancer Research|October 28, 1999
Germ-line msh6 mutations in colorectal cancer familiesR D Kolodner, J D Tytell, J L Schmeits, et al.
Cancer Research|July 17, 2001
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive historyT R Rebbeck, Y Wang, P W Kantoff, et al.
Journal of the National Cancer Institute|September 2, 1999
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriersT R Rebbeck, A M Levin, A Eisen, et al.
Science (New York, N.Y.)|January 5, 2000
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndromeD W Bell, J M Varley, T E Szydlo, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Docetaxel administered on a weekly basis for metastatic breast cancerH J Burstein, J Manola, J Younger, et al.
The New England Journal of Medicine|November 7, 1996
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1S C Rubin, I Benjamin, K Behbakht, et al.
Cancer Research|January 13, 2001
Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancerP Seth, K L Lunetta, D W Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programsM Dorval, A F Patenaude, K A Schneider, et al.
American Journal of Human Genetics|April 17, 1999
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeatT R Rebbeck, P W Kantoff, K Krithivas, et al.
Journal of Medical Genetics|July 31, 2007
Germline E-cadherin mutations in familial lobular breast cancerS Masciari, N Larsson, J Senz, et al.
Cancer Research|October 28, 1999
Germ-line msh6 mutations in colorectal cancer familiesR D Kolodner, J D Tytell, J L Schmeits, et al.
Cancer Research|July 17, 2001
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive historyT R Rebbeck, Y Wang, P W Kantoff, et al.
Journal of the National Cancer Institute|September 2, 1999
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriersT R Rebbeck, A M Levin, A Eisen, et al.
Science (New York, N.Y.)|January 5, 2000
Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndromeD W Bell, J M Varley, T E Szydlo, et al.
Pageof 8